{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:12:18Z","timestamp":1784632338426,"version":"3.55.0"},"reference-count":114,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Male hypogonadism is associated with metabolic and cardiovascular comorbidities, and emerging evidence implicates testosterone deficiency in immune dysregulation that may elevate cancer risk. To review current evidence on the relationship between male hypogonadism, immune function, and cancer risk, focusing on mechanisms linking testosterone deficiency to immune suppression and oncologic outcomes. PubMed\/MEDLINE, Google Scholar, and SciSpace were systematically searched (through April 2026) using predefined search strings. After removal of duplicates (n = 1535 records screened), 156 full-text articles were assessed for eligibility; 20 studies met predefined inclusion criteria (comprising 4 experimental studies, 4 prospective\/RCT studies, 7 observational studies, and 5 reviews used as secondary literature) and were included in a narrative synthesis. Testosterone deficiency was consistently associated with elevated IL-6, TNF-\u03b1, IL-1\u03b2, and CRP, impaired neutrophil maturation, and reduced NK-cell cytotoxicity. Androgen deprivation augmented thymic output and anti-tumor T cell responses in prostate cancer models, yet promoted chronic inflammation in other contexts. Epidemiologically, low testosterone correlated with increased colorectal cancer risk and poorer survival in advanced malignancies; the prostate cancer relationship followed a paradoxical saturation model. The immunological consequences of hypogonadism are context-dependent. Testosterone deficiency drives pro-inflammatory signaling that may promote carcinogenesis, while androgen-mediated immunosuppression can paradoxically impair anti-tumor surveillance. No simple linear relationship exists between hypogonadism and cancer risk via immune suppression. Prospective studies are needed to guide clinical decisions on testosterone replacement therapy in hypogonadal men.<\/jats:p>","DOI":"10.3390\/ijms27146406","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:32:54Z","timestamp":1784539974000},"page":"6406","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is Male Hypogonadism a Risk Factor for Cancer Through Weakening of the Immune System?"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7113-2372","authenticated-orcid":false,"given":"Sandro","family":"La Vignera","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5217-9343","authenticated-orcid":false,"given":"Rosita A.","family":"Condorelli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-019-0087-y","article-title":"Paediatric and adult-onset male hypogonadism","volume":"5","author":"Salonia","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMcp0707217","article-title":"Osteoporosis in men","volume":"358","author":"Ebeling","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1210\/jc.2016-3580","article-title":"A perspective on middle-aged and older men with functional hypogonadism: Focus on holistic management","volume":"102","author":"Grossmann","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/13685538.2015.1004049","article-title":"Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men","volume":"18","author":"Lunenfeld","year":"2015","journal-title":"Aging Male"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0911101","article-title":"Identification of late-onset hypogonadism in middle-aged and elderly men","volume":"363","author":"Wu","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gubbels Bupp, M.R., and Jorgensen, T.N. (2018). Androgen-induced immunosuppression. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00794"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cellimm.2015.02.004","article-title":"Suppressive effects of androgens on the immune system","volume":"294","author":"Trigunaite","year":"2015","journal-title":"Cell. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: A meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"ref_10","first-page":"e14147","article-title":"Testosterone and the immune system in males: A review","volume":"53","author":"Naguib","year":"2021","journal-title":"Andrologia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2011.07.019","article-title":"High serum testosterone is associated with reduced risk of cardiovascular events in elderly men","volume":"58","author":"Ohlsson","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIRCULATIONAHA.107.719005","article-title":"Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men","volume":"116","author":"Khaw","year":"2007","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1001\/archinte.166.15.1660","article-title":"Low serum testosterone and mortality in male veterans","volume":"166","author":"Shores","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/eurheartj\/ehq009","article-title":"Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20\u201379","volume":"31","author":"Haring","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.eururo.2008.09.024","article-title":"Shifting the paradigm of testosterone and prostate cancer: The saturation model and the limits of androgen-dependent growth","volume":"55","author":"Morgentaler","year":"2009","journal-title":"Eur. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.1073\/pnas.1402468111","article-title":"Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation","volume":"111","author":"Kissick","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1091\/mbc.10.10.3113","article-title":"Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages","volume":"10","author":"Benten","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.38048","article-title":"Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in sex-biased NZB\/W F1 mice","volume":"65","author":"Trigunaite","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.4049\/jimmunol.175.4.2741","article-title":"Activation of thymic regeneration in mice and humans following androgen blockade","volume":"175","author":"Sutherland","year":"2005","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.167.4.2060","article-title":"Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production","volume":"167","author":"Liva","year":"2001","journal-title":"J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.25429","article-title":"Regulatory T cells in tumor immunity","volume":"127","author":"Nishikawa","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E856","DOI":"10.1152\/ajpendo.00484.2005","article-title":"Effect of medical castration on CD4+CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: A physiological role for testosterone and\/or its metabolites","volume":"290","author":"Page","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1567-5769(01)00044-3","article-title":"Sex hormones as immunomodulators in health and disease","volume":"1","author":"Verthelyi","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"ref_24","first-page":"369","article-title":"Gonadal steroids and immunity","volume":"17","author":"Olsen","year":"1996","journal-title":"Endocr. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0091-6749(99)70503-8","article-title":"Estrogen enhances immunoglobulin production by human PBMCs","volume":"103","author":"Kanda","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1210\/jcem.85.1.6226","article-title":"The effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotropic hypogonadism","volume":"85","author":"Yesilova","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ccr.2014.04.026","article-title":"B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas","volume":"25","author":"Affara","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.intimp.2006.01.013","article-title":"Human NK cell IFN-gamma production is regulated by endogenous TGF-beta","volume":"6","author":"Meadows","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"ref_30","first-page":"399","article-title":"Lymphocyte subset distribution and natural killer cell activity in men with idiopathic hypogonadotropic hypogonadism","volume":"124","author":"Kiess","year":"1991","journal-title":"Acta Endocrinol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1152\/physrev.00033.2015","article-title":"Estrogens and androgens in skeletal physiology and pathophysiology","volume":"97","author":"Almeida","year":"2017","journal-title":"Physiol. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: In vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/js.2018-00186","article-title":"The anti-inflammatory effects of testosterone","volume":"3","author":"Bianchi","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"ref_36","first-page":"31","article-title":"Sex differences in innate immune responses to infection","volume":"6","author":"Crockett","year":"2003","journal-title":"J. Gend. Specif. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1385\/IR:34:3:177","article-title":"Sexual dimorphism in innate immune responses to infectious organisms","volume":"34","author":"Marriott","year":"2006","journal-title":"Immunol. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s10875-005-5635-4","article-title":"Naive T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: Implications for analysis of thymus function","volume":"25","author":"Sempowski","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"ref_39","first-page":"116","article-title":"The relationship between testosterone and molecular markers of inflammation in older men","volume":"28","author":"Maggio","year":"2005","journal-title":"J. Endocrinol. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2147\/CIA.S115472","article-title":"A concise review of testosterone and bone health","volume":"11","author":"Mohamad","year":"2016","journal-title":"Clin. Interv. Aging"},{"key":"ref_41","first-page":"1193","article-title":"High systemic immune-inflammation index predicts poor prognosis in patients with bladder cancer after radical cystectomy","volume":"199","author":"Wang","year":"2018","journal-title":"J. Urol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/gerona\/61.6.575","article-title":"Interleukin-6 in aging and chronic disease: A magnificent pathway","volume":"61","author":"Maggio","year":"2006","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.fertnstert.2008.05.040","article-title":"Persistence of androgenic effects on the production of proinflammatory cytokines by circulating antigen-presenting cells after withdrawal of testosterone treatment in aging type 2 diabetic men with partial androgen deficiency","volume":"92","author":"Corrales","year":"2009","journal-title":"Fertil. Steril."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1210\/jc.2004-0777","article-title":"Increased mortality in Klinefelter syndrome","volume":"89","author":"Bojesen","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2003-031069","article-title":"The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men","volume":"89","author":"Malkin","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/eje.1.02166","article-title":"Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes","volume":"154","author":"Kapoor","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1111\/j.1743-6109.2010.01931.x","article-title":"Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: Results from a 24-month, randomized, double-blind, placebo-controlled study","volume":"7","author":"Aversa","year":"2010","journal-title":"J. Sex. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijc.11572","article-title":"High levels of circulating testosterone are not associated with increased prostate cancer risk: A pooled prospective study","volume":"108","author":"Stattin","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/sj.bjc.6690445","article-title":"Endogenous sex hormones and prostate cancer: A quantitative review of prospective studies","volume":"80","author":"Eaton","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djm323","article-title":"Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies","volume":"100","author":"Hormones","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1097\/01.ju.0000158040.33531.e7","article-title":"Testosterone as a predictor of pathological stage in clinically localized prostate cancer","volume":"173","author":"Bianco","year":"2005","journal-title":"J. Urol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pros.1046","article-title":"High-grade prostate cancer is associated with low serum testosterone levels","volume":"47","author":"Schatzl","year":"2001","journal-title":"Prostate"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials","volume":"60","author":"Calof","year":"2005","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":"Clinical review 1: Adverse effects of testosterone therapy in adult men: A systematic review and meta-analysis","volume":"95","author":"Murad","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.eururo.2018.07.024","article-title":"Low free testosterone and prostate cancer risk: A collaborative analysis of 20 prospective studies","volume":"74","author":"Watts","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_57","first-page":"217","article-title":"Height, body weight, and risk of colorectal cancer","volume":"3","author":"Giovannucci","year":"1994","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1158\/1055-9965.EPI-04-0371","article-title":"Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era","volume":"14","author":"Platz","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_59","first-page":"197","article-title":"Testosterone therapy and risk of prostate cancer","volume":"25","author":"Hsi","year":"2015","journal-title":"Curr. Opin. Urol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","article-title":"Microbiota and diabetes: An evolving relationship","volume":"63","author":"Tilg","year":"2014","journal-title":"Gut"},{"key":"ref_61","first-page":"338","article-title":"Occult malignancy in patients with unprovoked pulmonary embolism","volume":"39","author":"Liao","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ijc.22814","article-title":"Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition","volume":"121","author":"Travis","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/dji240","article-title":"Cancer incidence and mortality in men with Klinefelter syndrome: A cohort study","volume":"97","author":"Swerdlow","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1158\/1055-9965.EPI-06-0499","article-title":"Usefulness of body mass index as a sufficient adiposity measurement for sex hormone concentration associations in postmenopausal women","volume":"15","author":"Mahabir","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1525-1438.2007.00790.x","article-title":"Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis","volume":"17","author":"Chia","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_66","first-page":"1049","article-title":"Serum testosterone level and the risk of hepatocellular carcinoma","volume":"10","author":"Cai","year":"2021","journal-title":"Endocr. Connect."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1464-410X.2008.08183.x","article-title":"The efficacy and safety of degarelix: A 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer","volume":"102","author":"Klotz","year":"2008","journal-title":"BJU Int."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2011.08.041","article-title":"Androgen-deprivation therapy and the risk of bladder cancer in patients with prostate cancer","volume":"60","author":"Azoulay","year":"2011","journal-title":"Eur. Urol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jnci\/djp404","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy: Observational study of veterans with prostate cancer","volume":"102","author":"Keating","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archgenpsychiatry.2007.33","article-title":"Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men","volume":"65","author":"Almeida","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_71","first-page":"295","article-title":"Testicular dysgenesis syndrome predisposes to testicular neoplasia, is linked to disturbances in male reproductive development and is associated with epigenetic changes","volume":"33","author":"Tvermosegaard","year":"2010","journal-title":"Int. J. Androl."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.amjmed.2010.12.027","article-title":"Testosterone deficiency","volume":"124","author":"Traish","year":"2011","journal-title":"Am. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.humimm.2010.02.007","article-title":"Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses","volume":"71","author":"Morse","year":"2010","journal-title":"Hum. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.4049\/jimmunol.173.10.6098","article-title":"Augmentation of T cell levels and responses induced by androgen deprivation","volume":"173","author":"Roden","year":"2004","journal-title":"J. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1210\/jc.2011-0118","article-title":"Low testosterone in men with type 2 diabetes: Significance and treatment","volume":"96","author":"Grossmann","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2164\/jandrol.108.007245","article-title":"The dark side of testosterone deficiency: III. Cardiovascular disease","volume":"30","author":"Traish","year":"2009","journal-title":"J. Androl."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: A consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/oxfordjournals.aje.a008832","article-title":"Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial","volume":"143","author":"Haffner","year":"1996","journal-title":"Am. J. Epidemiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1079\/PNS200070","article-title":"Energy balance and cancer: The role of insulin and insulin-like growth factor-I","volume":"60","author":"Kaaks","year":"2001","journal-title":"Proc. Nutr. Soc."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.mayocp.2016.04.007","article-title":"Fundamental concepts regarding testosterone deficiency and treatment: International expert consensus resolutions","volume":"91","author":"Morgentaler","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.2337\/db09-0031","article-title":"Prediction of metabolic syndrome by low serum testosterone levels in men: Results from the Study of Health in Pomerania","volume":"58","author":"Haring","year":"2009","journal-title":"Diabetes"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1210\/jc.2003-031719","article-title":"Prevalence and incidence of androgen deficiency in middle-aged and older men: Estimates from the Massachusetts Male Aging Study","volume":"89","author":"Araujo","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Figueiredo, J.C., Hsu, L., Hutter, C.M., Lin, Y., Campbell, P.T., Baron, J.A., Berndt, S.I., Jiao, S., Casey, G., and Fortini, B. (2014). Genome-wide diet-gene interaction analyses for risk of colorectal cancer. PLoS Genet., 10.","DOI":"10.1371\/journal.pgen.1004228"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","article-title":"NF-\u03baB: Linking inflammation and immunity to cancer development and progression","volume":"5","author":"Karin","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-151-9-200911030-00151","article-title":"Hormonal testing and pharmacological treatment of erectile dysfunction: A clinical practice guideline from the American College of Physicians","volume":"151","author":"Qaseem","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and management of testosterone deficiency: AUA guideline","volume":"200","author":"Mulhall","year":"2018","journal-title":"J. Urol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/jsm.12546","article-title":"Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions","volume":"11","author":"Morgentaler","year":"2014","journal-title":"J. Sex. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/jsm.12536","article-title":"Testosterone supplementation and sexual function: A meta-analysis study","volume":"11","author":"Corona","year":"2014","journal-title":"J. Sex. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/jsm.12146","article-title":"Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes","volume":"10","author":"Hackett","year":"2013","journal-title":"J. Sex. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/pcan.2013.60","article-title":"The effect of testosterone replacement therapy on prostate cancer: A systematic review and meta-analysis","volume":"17","author":"Cui","year":"2014","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2164\/jandrol.05047","article-title":"Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations","volume":"27","author":"Nieschlag","year":"2006","journal-title":"J. Androl."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2164\/jandrol.108.005751","article-title":"The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance","volume":"30","author":"Traish","year":"2009","journal-title":"J. Androl."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1210\/jc.2006-0401","article-title":"Association of specific symptoms and metabolic risks with serum testosterone in older men","volume":"91","author":"Zitzmann","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/1740774514524032","article-title":"The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men","volume":"11","author":"Snyder","year":"2014","journal-title":"Clin. Trials"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1210\/jc.2008-1902","article-title":"The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men","volume":"94","author":"Brambilla","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: Utility, limitations, and pitfalls in measuring testosterone: An Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1210\/jc.2011-1137","article-title":"Clinical review: Endogenous testosterone and mortality in men: A systematic review and meta-analysis","volume":"96","author":"Araujo","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0140-6736(91)90201-Y","article-title":"Publication bias in clinical research","volume":"337","author":"Easterbrook","year":"1991","journal-title":"Lancet"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.286.7.821","article-title":"Comparison of evidence of treatment effects in randomized and nonrandomized studies","volume":"286","author":"Ioannidis","year":"2001","journal-title":"JAMA"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1210\/jc.2013-3375","article-title":"Requirement for mass spectrometry sex steroid assays","volume":"98","author":"Handelsman","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/er.2002-0032","article-title":"Androgen receptor in prostate cancer","volume":"25","author":"Heinlein","year":"2004","journal-title":"Endocr. Rev."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/bjc.2011.189","article-title":"The prognostic influence of tumour-infiltrating lymphocytes in cancer: A systematic review with meta-analysis","volume":"105","author":"Gooden","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.eururo.2004.01.005","article-title":"Hormonal supplementation and erectile dysfunction","volume":"45","author":"Aversa","year":"2004","journal-title":"Eur. Urol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2265.2005.02339.x","article-title":"Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: A meta-analysis","volume":"63","author":"Isidori","year":"2005","journal-title":"Clin. Endocrinol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6406\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:37:55Z","timestamp":1784630275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":114,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27146406"],"URL":"https:\/\/doi.org\/10.3390\/ijms27146406","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]}}}